News
9 July 2025 Two pivotal rulings regarding the use of copyrighted works to train genAI models may reshape the legal landscape ...
22 April 2024 Multinational conglomerate filed a lawsuit against a Florida-based travel company, and its directors | ...
Partner spent time as senior counsel at Forrest Weldon | New hire will be instrumental in developing next generation of IP ...
Design and colour combination deemed ‘too common’ in the pharma sector for protection | Court says trademarks must be ...
22 July 2024 Court determined that artificial neural networks cannot be patented as they are considered computer programs | ...
‘Bewildering’ arguments heard in major UK patent hearing at UK Supreme Court | Cluedo analogy and famous tracks used by UKIPO ...
This LSPN session features experts from EIP, The Broad Institute of MIT and Harvard, Pfizer, and an independent specialist ...
Stephen Thaler’s next DABUS hearing at the UK High Court puts the inventorship test on trial. Thaler's counsel Ryan Abbott ...
Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...
US State Department has said it is engaging with Chinese officials to resolve situation | Federal employee failed to disclose he worked for US government, according to a report. Already registered?
Important cases on discretionary denials, prosecution latches, and trade secrets have been heard at the appellate court over June and July, explain Nathan Mammen and Cole Tipton of Snell & Wilmer.
Far from a wave of refusals, the major trademark decision was followed by pragmatic and reassuring advice from the IP office, says Jade MacIntyre of Lewis Silkin. If you don't have a login or your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results